FDA approves Vobrig (leuprolide acetate) - FDA New Drug Approvals - Nundina

Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Vobrig (leuprolide acetate)FDA approves Vobrig (leuprolide acetate)26 August 2026The FDA approved Vobrig (leuprolide acetate), a drug from Sun Pharm. Form: Solution, Subcutaneous. Application NDA213225.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)